Human rIL-2 (10-30 micrograms) was injected intradermally into the skin of patients with lepromatous leprosy with high bacillary loads. All patients responded to the lymphokine with local areas of induration that peaked at 24 h and persisted for 4-7 d irrespective of whether the site was "normal skin" or a nodular lesion. Within 24 h there was an extensive emigration of T cells and monocytes into the site. The percentage of the dermis infiltrated by mononuclear cells increased by more than sevenfold, peaking at 4 d and persisting for greater than 15 d. Both CD4+ and CD8+ T cells entered the site. T cells of CD4+ phenotype predominated at 2-7 d but by 11 d, CD8+ cells were predominant. Considerable numbers of T6+ Langerhans' cells appeared in the dermis by 72 h and persisted for 3 wk. By 4 d the thickness of the overlying epidermis had increased twofold, and keratinocytes were expressing MHC class II antigen and the IFN-gamma-induced peptide IP-10. Starting at 48 h, there was an extensive destruction of mononuclear phagocytes that contained structurally intact or fragmented M. leprae observed at the electron microscope level. The organisms, either free or contained within endocytic vacuoles, were discharged into the extracellular space and then reingested by blood-borne monocytes. This was followed by marked reductions in the number of acid-fast organisms in the injected site, evident as early as 4-7 d and more marked at 2-3 wk after injection. 13 of 15 patients exhibited a disposal of acid-fast bacilli ranging from 5- to 1,000-fold with a mean value of approximately 100-fold. The administration of IL-2 leads to the generation of an effective cell-mediated immune response, recapitulating an antigen-driven event and leading to striking local reductions in M. leprae. In comparison with the purified protein derivative of tuberculin reaction, bacilli are cleared more promptly, although emigratory cells persist for a shorter time.
Skip Nav Destination
Article navigation
1 March 1989
Article|
March 01 1989
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
G Kaplan,
G Kaplan
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
R Kiessling,
R Kiessling
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
S Teklemariam,
S Teklemariam
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
G Hancock,
G Hancock
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
G Sheftel,
G Sheftel
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
C K Job,
C K Job
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
P Converse,
P Converse
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
T H Ottenhoff,
T H Ottenhoff
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
M Becx-Bleumink,
M Becx-Bleumink
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
M Dietz
M Dietz
Rockefeller University, New York, New York 10021.
Search for other works by this author on:
G Kaplan
,
R Kiessling
,
S Teklemariam
,
G Hancock
,
G Sheftel
,
C K Job
,
P Converse
,
T H Ottenhoff
,
M Becx-Bleumink
,
M Dietz
Rockefeller University, New York, New York 10021.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1989) 169 (3): 893–907.
Citation
G Kaplan, R Kiessling, S Teklemariam, G Hancock, G Sheftel, C K Job, P Converse, T H Ottenhoff, M Becx-Bleumink, M Dietz; The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.. J Exp Med 1 March 1989; 169 (3): 893–907. doi: https://doi.org/10.1084/jem.169.3.893
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement